A range of Covid-19 vaccines are being developed worldwide. Which ones are authorised and assessed in the EU? Which are still in development? Check our table below.
| Company | Type | Efficacy* | Doses | Storage | Status in Europe* | Secured by EU |
|---|---|---|---|---|---|---|
|
Pfizer / BioNTech 🇩🇪🇺🇸 |
mRNA* |
💉💉 (💉) |
2.4 bn |
|||
|
Moderna 🇺🇸 |
mRNA |
💉💉 (💉) |
-20°C |
460 mn |
||
|
AstraZeneca / Oxford 🇸🇪🇬🇧 |
Adenovirus-vectored technology*
|
💉💉 |
Fridge |
400 mn |
||
|
Johnson&Johnson / Janssen 🇧🇪🇺🇸 |
Adenovirus-vectored technology
|
💉 |
Fridge |
400 mn |
||
|
Novavax 🇸🇪🇺🇸 |
Protein
|
89.3% |
💉💉 |
Fridge |
~200 mn |
|
|
CVnCoV – CureVac AG 🇩🇪 |
mRNA
|
❔ |
💉💉 |
Fridge |
405 mn |
|
|
Sputnik V – Gamaleya Research Institute 🇷🇺 |
Adenovirus-vectored technology
|
💉💉 |
-18°C |
Rolling review Emergency use in Hungary, BiH, Serbia, Montenegro |
|
|
|
CoronaVac – Sinovac 🇨🇳 |
Inactivated virus
|
💉💉 |
Fridge |
Rolling review Emergency use in Turkey |
|
|
|
BBIBP-CorV – Sinopharm 🇨🇳 |
Inactivated virus
|
💉💉 |
Fridge |
Emergency use in Hungary, Serbia |
|
|
|
VLA2001 – Valneva 🇫🇷 |
Inactivated virus
|
❔ |
❔ |
Fridge |
~60 mn |
|
|
Sanofi & GSK 🇫🇷 (x2 vaccines) |
mRNA & protein |
❔ |
❔ |
❔ |
Rolling review of Vidprevtyn |
300 mn |
• Efficacy: numbers vary in different sources
• mRNA: messenger RNA, part of the virus’ genetic code
• Adenovirus-vectored technology: genetically modified cold virus
• Status in Europe: overview of the situation in EU and in the candidates/potential candidates countries.
Sources: WHO, EMA, EC, Astrazeneca, Sanofi, JnJ, Novavax, SputnikVaccine, TheLancet, Nature & other.
Last update : 29 June 2022